ResMed News

Resmed Stock Poised for Growth: Buy Rating Affirmed Amid Revenue Upswing and Margin Expansion

TipRanksApr 17 05:10 ET

Analysts Offer Insights on Healthcare Companies: Novartis AG (Six Swiss: CH:NOVN), Carl Zeiss Meditec (GB:0DHC) and Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (AU:RMD)

TipRanksApr 17 05:06 ET

Analysts Are Bullish on Top Healthcare Stocks: InMode (INMD), Resmed (RMD)

TipRanksApr 12 01:50 ET

Analyst Upgrades Resmed Price Target to $224, Maintains Buy Rating Amidst Market Opportunities and OSA Trial Developments

TipRanksApr 1 05:35 ET

ResMed Analyst Ratings

BenzingaApr 1 05:19 ET

Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Merck & Company (MRK)

TipRanksMar 28 00:20 ET

ResMed Analyst Ratings

BenzingaMar 27 13:14 ET

Morgan Stanley Adjusts Resmed's Price Target to AU$31.80 From AU$28.60, Keeps at Overweight

MT NewswiresMar 5 21:16 ET

Evans & Partners Upgrades ResMed to Positive From Neutral, Price Target Is AU$31

MT NewswiresMar 4 03:13 ET

ResMed Analyst Ratings

BenzingaFeb 6 07:08 ET

Oppenheimer Keeps Their Buy Rating on Resmed (RMD)

TipRanksJan 30 23:15 ET

Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Demant (OtherWILLF)

TipRanksJan 30 20:51 ET

ResMed Analyst Ratings

BenzingaJan 30 09:39 ET

Oppenheimer Raises ResMed Price Target to $205 From $185, Maintains Outperform Rating

MT NewswiresJan 30 09:33 ET

Resmed Stock Buy Rating Affirmed Amidst Market Opportunity and Strong Financials

TipRanksJan 29 07:36 ET

ResMed Analyst Ratings

BenzingaJan 26 14:41 ET

Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Resmed (RMD) and Clinigence Holdings (NUTX)

TipRanksJan 25 07:32 ET

Resmed Receives Strong Buy Rating on Robust Sales, Margin Expansion, and Promising Treatment Synergies

TipRanksJan 25 06:25 ET

ResMed Analyst Ratings

BenzingaJan 25 06:10 ET

Buy Rating Affirmed for Resmed on Strong Financials and Positive Strategic Outlook

TipRanksJan 25 06:05 ET